A recent article was published about the new partnership of the company Tempus and the University of Chicago Medicine. This partnership is designed to work together to create a treatment for cancer that is individualized for each patient, and eventually to hopefully find a cure. Tempus uses new technologies, including machine learning and molecular sequencing to figure out which treatments will work best with each individual patient’s genetic makeup. These new technologies could be a huge gamechanger in the both the medical field, with doctors and patients better able to fight cancer, but also in the “cancer business.” Current cancer treatment is extremely expensive, and only a handful of companies rule the market. However, this new and very disruptive form of technology could turn the entire industry on its head. Eric Lefkofsky, founder of Tempus, is the master of disruptive technologies.
Eric Lefkofsky has devoted his life to creating companies focused on technology and getting it to consumers. He is the co-founder of several different technology manufacturing, logistics, investment, and research companies, and he has devoted his life to the theoretical and practical application of these technologies. Lefkofsky is also a professor of applied technology and disruptive business modeling at the University of Chicago, and has had jobs at both DePaul University and Northwestern University as well.
When he is not creating new tech, Eric Lefkofsky is helping his wife run the Lefkofsky Family Foundation. This private, charitable foundation focuses on helping organizations that have an impact on their communities around the Chicago are. To date, the Foundation has helped over 50 organizations with new projects and initiatives. Lefkofsky is also on the Board of Trustees for many different organizations, including the Children’s Hospital of Chicago and the Art Institute of Chicago. Through his work with new technology and his philanthropic tendencies, Eric Lefkofsky is truly trying to make the world a better place.